LianBio (LIANY)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Yi Z. Wang |
| Employees: | 110 |
| Web site: | lianbio.com |
|
103 CARNEGIE CENTER DRIVE, SUITE 309, PRINCETON, NJ, 08540
(609) 486-2308
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the. treatment of Demodex blepharitis.
Please log in first to see chart